EFFECTS OF PRAZOSIN AND PROPRANOLOL ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:51
|
作者
LOWENSTEIN, J
NEUSY, AJ
机构
来源
AMERICAN JOURNAL OF MEDICINE | 1984年 / 76卷 / 2A期
关键词
D O I
10.1016/0002-9343(84)90960-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:79 / 84
页数:6
相关论文
共 50 条
  • [1] THE EFFECTS OF PRAZOSIN AND PROPRANOLOL ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    NEUSY, AJ
    LOWENSTEIN, J
    [J]. CLINICAL RESEARCH, 1983, 31 (02): : A251 - A251
  • [2] EFFECT OF BEVANTOLOL AND PROPRANOLOL ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    SASAKI, J
    KAJIYAMA, G
    KUSUKAWA, R
    MORI, H
    KOGA, S
    TAKAGI, R
    TANAKA, N
    OGAWA, N
    ARAKAWA, K
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (12) : 660 - 664
  • [3] COMPARATIVE EFFECTS OF BUNAZOSIN AND PROPRANOLOL ON SERUM-LIPIDS AND APOLIPOPROTEINS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    SASAKI, J
    KOGA, S
    UZAWA, H
    ARAKAWA, K
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1989, 27 (08) : 402 - 407
  • [4] EFFECTS OF CARVEDILOL ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    GOTO, Y
    TAMACHI, H
    FUSEGAWA, Y
    NAKAYA, N
    HOMMA, Y
    MIKAMI, M
    IORI, S
    YAMAZAKI, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S45 - S50
  • [5] SERUM-LIPIDS AND APOLIPOPROTEINS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    CATALANO, M
    ARONICA, A
    CARZANIGA, G
    SEREGNI, R
    LIBRETTI, A
    [J]. ATHEROSCLEROSIS, 1991, 87 (01) : 17 - 22
  • [6] EFFECTS OF KETANSERIN TARTRATE ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    NAKAMURA, H
    HIRATA, F
    YASUGI, T
    MIZUNO, M
    SAITO, E
    ISHIKAWA, T
    TADA, N
    NAKAYA, N
    HOMMA, Y
    TAKEUCHI, I
    [J]. DRUGS, 1988, 36 : 25 - 34
  • [7] EFFECTS OF BEVANTOLOL AND PROPRANOLOL ON BLOOD-PRESSURE, SERUM-LIPIDS, AND LIPOPROTEINS IN ESSENTIAL-HYPERTENSION
    KOSKINEN, P
    PELLINEN, TJ
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (06): : 952 - 960
  • [8] TERAZOSIN - SAFETY AND EFFICACY IN ESSENTIAL-HYPERTENSION, AND EFFECTS ON SERUM-LIPIDS
    DIETZ, AJ
    MAGARIAN, E
    FREEMAN, D
    CARLSON, J
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (8-9): : 416 - 416
  • [9] EFFECTS OF PINDOLOL ON SERUM-LIPIDS, APOLIPOPROTEINS, AND LIPOPROTEINS IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    SASAKI, J
    SAKU, K
    IDEISHI, M
    ARAKAWA, K
    KATO, Y
    KUWANO, E
    SO, T
    [J]. CLINICAL THERAPEUTICS, 1989, 11 (02) : 219 - 224
  • [10] SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN UNTREATED ESSENTIAL-HYPERTENSION
    DONMA, O
    DONMA, MM
    KAHRAMAN, D
    UYGUR, H
    SAGLIKER, Y
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1993, 7 (03) : 311 - 313